Skip to main content
Premium Trial:

Request an Annual Quote

UCal and Evotec Win Recent Cell Based Assay-Related Patents


The University of California has been awarded US Patent No. 6,927,049, "Cell viability detection using electrical measurements."

Inventors listed on the patent are Boris Rubinsky and Yong Huang.

According to its abstract, the patent protects a method of determining information about cell viability and other characteristics relating to cell membrane permeability. The method involves determining the effect of a cell on current flow and relating that effect to a known standard, which may be a known healthy cell, and thereby deducing the viability of the cell being tested, the abstract states. The cells being tested can be subjected to different environmental conditions such as surrounding chemicals, temperature, pH, and pressure to determine the effects of such conditions on cell viability and/or cell permeability. The cell being tested can be in a cell suspension, grown on substrate, in tissue in vitro, or in tissue in vivo. The method provides substantially instantaneous results and need not include the use of dyes or other markers, the abstract states.

Evotec has been awarded US Patent No. 6,927,401, "Method of characterizing fluorescent molecules or other particles using generating functions."

Kaupo Palo is the lone inventor listed on the patent.

According to its abstract, the patent protects a method for characterizing fluorescent molecules or other particles in samples comprising the steps of (a) monitoring fluctuating intensity of fluorescence emitted by the molecules or other particles in at least one measurement volume of a non-uniform spatial brightness profile by measuring numbers of photon counts in primary time intervals by a single or more photon detectors; (b) determining at least one distribution of numbers of photon counts from the measured numbers of photon counts; and (c) determining physical quantities characteristic to said particles by fitting the distribution of numbers of photon counts, wherein the fitting procedure involves calculation of a theoretical distribution function of the number of photon counts through its generating function.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.